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Pleomorphic adenoma (PA) is the most common salivary gland tumor and its microscopic features and histogenesis are a matter of debate. Human milk fat globule protein 
membrane (HMFG) monoclonal antibodies (MoAbs) comprise a set of antibodies against the 
mucin 1 (MUC-1) protein detected in several salivary gland tumors. Objective: The aim of 
this study was to assess the immunoexpression of the PA neoplastic cells to MUC-1 protein 
using HMFG-1 and HMFG-2 MoAbs, contrasting these results with those from normal salivary 
gland tissue. Material and Methods: Immunohistochemical detection of MUC-1 protein 
using HMFG-1 and HMFG-2 MoAbs was made in 5 mm thick, paraffin embedded slides, and 
the avidin-biotin method was used. Results: Positivity to HMFG-1 and HMFG-2 MoAbs was 
found in ductal, squamous metaplastic and neoplastic myoepithelial cells, keratin pearls 
and intraductal mucous material. Two kinds of myoepithelial cells were identified: classic 
myoepithelial cells around ducts were negative to both MoAbs, and modified myoepithelial 
cells were positive to both MoAbs. This last cellular group of the analyzed tumors showed 
similar MUC-1 immunoexpression to ductal epithelial cells using both HMFG antibodies. 
Intraductal mucous secretion was also HMFG-1 and HMFG-2 positive. Conclusions: Our 
results showed there are two kinds of myoepithelial cells in PA. The first cellular group is 
represented by the different kinds of neoplastic myoepithelial cells and is HMFG-positive. 
The second one is HMFG-negative and represented by the neoplastic myoepithelial cells 
located around the ducts.
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INTRODUCTION
Pleomorphic adenoma (PA) is the most common 
epithelial neoplasm arising in the salivary gland 
tissue; it is more frequently found in palate and is 
more common in males7. Racial differences among 
age, gender and location have been reported7,15,16.
Human milk fat globule membrane (HMFG) 
is part of the apical cell membrane of the 
secretory mammary cells and it contains several 
differentiation antigens3. Two of them are HMFG-1 
and HMFG-2 monoclonal antibodies (MoAbs), which 
are directed against the oligosaccharide side chains 
of glycoprotein components of this structure1.
Anti-HMFG-1 and -2 comprise a set of monoclonal 
antibodies against the mucin 1 (MUC-1) protein and 
they have been found in breast malignant tumors25 
and in different benign tumors and malignancies 
from several organs1,5,6,8-13,17,27. The presence 
of HMFG membrane-derived antigens has been 
correlated with differentiation and prognosis13,26,27. 
To date, the presence of the epitopes of MUC-1 
protein using HMFG-1 and -2 monoclonal antibodies 
has been demonstrated in several salivary gland 
tumors4,19,23,28. We were able to find only few 
studies on the expression of HMFG-1 in pleomorphic 
adenomas4,21,24.
The aim of this study was to assess the 
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immunoexpression of the PA neoplastic cells to 
MUC-1 protein using HMFG-1 and HMFG-2 MoAbs 
and to compare these results with those from 
normal salivary gland tissue.
MATERIAL AND METHODS
All examples of salivary gland tumors were 
collected from the files of the Clinical Oral Pathology 
Laboratory of the Facultad de Odontología of 
Universidad Nacional Autónoma de México in Mexico 
City, and PA cases were separated. Hematoxylin 
and eosin (H&E) stained slides were available in 
every case. All cases were microscopically reviewed 
and diagnoses were re-evaluated according to the 
World Health Organization (WHO) International 
Classification of Salivary Gland Tumours2. Additional 
sections were stained with Periodic acid–Schiff 
(PAS), alcian blue and Hale’s coloidal iron stains. 
Normal tissues from labial, submandibular and 
parotid salivary glands were used as controls.
Cells in PAs were classified as epithelial and 
myoepithelial cells (MyECs). Epithelial cells were 
categorized as ductal and non-ductal cells, this last 
cellular set being formed by metaplastic squamous 
cells, keratin pearls and cells in solid epithelial-like 
areas. MyECs were divided into two sets: those 
found around the ductal structures were named 
classic myoepithelial cells (CMyECs); modified 
myoepithelial cells (MMyECs) were those found 
forming variable sized groups of spindle-shaped, 
plasmacytoid (hyaline) clear cells. MyECs associated 
to chondroid, myxoid, hyaline or mucoid areas were 
also considered in the last group. MyECs in normal 
salivary glands were all considered as CMyECs.
Methodology for synthesis and immunological 
features of the HMFG-1 and -2 MoAbs used in 
this study was described in detail by Arklie, et 
al.1 (1981), Ceriani, et al.3 (1979) and Taylor-
Papadimitrou, et al.26 (1981). Immunohistochemical 
detection of MUC-1 protein using HMFG-1 and 
HMFG–2 MoAbs was conducted according to a 
previous publication14. Briefly, immunostaining 
was made in 5 µ thick, paraffin embedded slides, 
later rinsed with PBS solution. All sections were 
treated with H2O2 for one hour to inhibit endogenous 
peroxidase activity and incubated for 10 min 
with 10% normal horse serum. Then, they were 
incubated overnight at 4°C with HMFG-1 (1:100 
dilution) and HMFG-2 (1:40 dilution) MoAbs and 
the avidin-biotin method was used. Peroxidase 
activity was detected using 3,3’-diaminobenzidine 
tetrahydrocloride as the substrate and all slides 
were counterstained with Harris hematoxylin. 
Control was normal labial salivary gland tissue 
treated with the same techniques. Negative controls 
were made omitting the antibody. Immunostaining 
grading was the same used in a previously published 




No morphological alterations were seen in the 
labial, submandibular and parotid gland examined 
tissues. Microscopic review of the 24 PA analyzed 
cases showed they were composed by different 
Figure 1- Photomicrograph showing the classic microscopic features of a pleomorphic adenoma. 100×. Hematoxylin & 
eosin
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structures in variable quantities: sheets and groups 
of epithelial polygonal cells, ductiform structures, 
squamous metaplastic cells, keratin pearls; MMyECs 
were fusiform, hyaline and clear, combined with 
variable quantities of hyaline, mucoid, myxoid 
and chondroid areas accompanied by eosinophilic 
coagula within the ducts (Figure 1).
Immunohistochemical findings
Data on the immunohistochemical findings is 
presented in Figure 2.
Normal salivary glands
In labial salivary glands, immunopositivity 
to both MoAbs was 1+ in the ductal cells, and it 
varied from 1+ to 2+ in the mucous acinic cells. 
No immunostaining was observed in the intraductal 
secretion and CMyECs with both employed MoAbs 
(Figure 3).
In submandibular salivary gland (SMSG) 
specimens, HMFG-1 immunostaining varied from 
1+ to 3+ in the ductal striated cells and from 3+ to 
4+ in the intralobular ductal cells. Serous acini were 
2+ to 3+ and mucous secreting cells varied from 
2+ to 4+. Intraductal secretion immunostaining 
varied from 1+ to 2+ (Figure 4A). With HMFG-2, 
ductal cells in SMSG had a staining intensity from 
1+ to 4+ and there was negative staining in both 
the serous and mucous secretory cells. Intraductal 
secretions stained 1+ to 2+ (Figure 4B).
In  paro t id  sa l i va ry  g lands ,  HMFG-1 
immunostaining was 1+ in some acinic cells and 3+ 
in ductal cells. Immunopositivity in secretion was 2+ 
(Figure 5A). In parotid gland cells, immunopositivity 
to HMFG-2 antibody was from 1+ to 2+ in the ductal 
cells and more intense in their apical portions. There 
was 1+ positivity in some groups of acinar cells and 
immunostaining in intraductal secretions was from 
1+ to 2+ (Figure 5B). MUC-1 immunoexpression 
is shown in Figure 2.
Figure 3- Normal labial salivary gland tissue showing slight immunoexpression to HMFG-2 antibody. 400×. HMFG-2 
MoAb. Avidin-biotin method
TYPE OF CELL HMFG-1 HMFG-2
LABIAL GLANDS
Mucous acinar cells 1-2 1-2
Ductual cells 1 1
CMyECs 0 0
Intraductal secretion 0 0
SUBMANDIBULAR GLANDS
Mucous cells 2-4 0
Serous cells 2-3 0
Striated duct cells 1-3 1-4
Intralobular duct cells 3-4 1-4
CMyECs 0 0
Intraductual secretion 1-2 1-2
PAROTID GLANDS
Serous cells 1 1
Ductal cells 3 1-2
CMyECs 0 0
Intraductal secretion 2 1-2
CMyECs=classic myoepithelial cells
Immunoreactivity: 0=negative; 1=slight; 2=moderate; 
3=strong; 4=very strong
Figure 2- Immunoexpression in normal control salivary 
glands
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Pleomorphic adenoma cases
Not all the slides from the studied PA cases were 
stained with both HMFG antibodies since, despite 
several efforts, four cases were negative. Three 
PAs were negative to HMFG-1 MoAb and one PA 
did not stain with HMFG-2 MoAb. No differences in 
immunostaining intensity were found when it was 
correlated with gender, age or location.
HMFG-1
In the positive tumors, immunostaining intensity 
to HMFG-1 varied from slight to strong. In seven 
cases (31.8%), slight intensity was found, in 12 
cases (54.6%) it was moderate, and in three 
Figure 4- MUC-1 immunoexpression in normal submandibular salivary gland tissue. A) HMFG-1 immunopositivity. 100×. 
B) Immunoexpression to HMFG-2. 100×. HMFG-1 and HMFG-2 MoAbs. Avidin-biotin method
Figure 5- MUC-1 immunoexpression in normal parotid salivary gland tissue. A) HMFG-1 immunopositivity. 100×. B) 
Immunoexpression to HMFG-2. 100×. HMFG-1 and HMFG-2 MoAbs. Avidin-biotin method
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cases (13.6%) intensity was strongly expressed. 
Positivity was found in the neoplastic ductal cells. 
Immunostaining of these cells varied from slight to 
strong and it was slight in the intraductal secretion 
(Figure 6A). Polyhedral non-ductal cells showed 
moderate to strong immunoreaction (Figure 6B). 
CMyECs were not stained with this MoAb. Other 
MMyECs showed slight to intense immunoreactivity. 
Characteristically, neoplastic interstitial tissue 
stained from slight to moderate with this MoAb. 
Detailed immunoreactivity of these cells is shown 
in Figure 7.
HMFG-2
In 24 positive cases, immunoreactivity varied 
from slight to strong. In 5 cases it was slight 
(20.8%); 11 cases (45.8%) showed moderate 
intensity and in eight cases (33.3%) it was strong. 
Ductal neoplastic cells immunostaining varied from 
slight to strong and, as in HMFG-1 MoAb, CMyECs 
did not show immunoreaction. Intraductal secretion 
showed slight immunoreactivity (Figure 8A). 
MMyECs immunoreactivity also varied from slight to 
strong (Figure 8B). Immunoreactivity of these cells 
to HMFG-2 MoAbs is shown in Figure 7. Data in this 
table show that MMyECs and ductal epithelial cells 
in PAs presented similar MUC-1 immunoexpression 
using both HMFG antibodies.
DISCUSSION
This is the first report on the presence of MUC-
1 protein in PAs using both HMFG-1 and HMFG-2 
MoAbs in pleomorphic adenomas. Findings on the 
existence of these proteins in normal submandibular 
and parotid salivary gland tissues were previously 
reported and discussed by our study group14. In 
this study, immunopositivity to both antibodies was 
found in normal secretory and ductal cells from all 
three tested kinds of salivary glands and negativity 
in the CMyECs surrounding these structures.
The milk fat globule membrane is an important 
component of the mammalian milk, it contains 
several proteins and glycoproteins, which are 
useful markers for cellular differentiation in diverse 
tissues and were identified in several kinds of 
tumors1,3,5,6,8-13,17,26,27. The HMFG-1 monoclonal 
antibody mainly reacts with lactating breast, and 
has been found in several benign and malignant 
tumors1,5,6,12,13,17,23. The HMFG-2 antigen is strongly 

































Immunoreactivity: 0=negative;  1=slight; 2=moderate; 
3=strong.
Figure 7- MUC-1 immunoexpression in pleomorphic 
adenoma cells
Figure 6- A) Neoplastic ductal structures showing variable immunoexpression to HMFG-1 antibody. No staining is shown 
by the myoepithelial cells around the ducts. 400×. B) Neoplastic cells with moderate to intense immunostaining. 400×. All 
photomicrographs. HMFG-1 MoAb. Avidin-biotin method
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expressed in carcinomas9-12,22,23,26,27.
MoAbs tested in this study have been used in 
a limited number of salivary gland tumours18-24,28, 
including those using PA neoplastic tissue4,5,24.
In the Hamada, et al.4 (2004) study, none of 40 
non-recurrent PA cases were positive to HMFG-1. 
In this article, the authors claimed that only one 
recurrent PA case was positive to HMFG-1, but their 
table indicates that two cases showed positivity 
(one parotid and one submandibular tumor). These 
results contrast with those from our study; we 
found immunoexpression to both antibodies in both 
neoplastic cell compartments of the analyzed PAs. 
In the neoplastic epithelial compartment, positive 
cells were: ductal epithelial cells, epithelial-like 
cells in solid areas, metaplastic squamous epithelial 
cells and keratin pearls. Also, in the mesenchymal-
like neoplastic compartment, cells composing the 
hyaline, myxoid and chondroid zones and the 
fusiform, plasmacytoid and clear MMyECs were also 
stained with variable intensities. Our findings are 
similar to those described in other works, which 
found immunoexpression with these antibodies in 
similar structures from different neoplasms9,17,28.
Our results are quite different from those 
obtained in the study of Hamada, et al.4 (2004). 
Theirs showed that only one (maybe two) PA 
case was positive to HMFG-1; in contrast, our 
study showed that 88% of our PAs were positive. 
Additionally, 23 of our 24 PA tested cases presented 
immunopositivity to HMFG-2.
In this study, we found that both HMFG antigens 
were expressed in every cell of the neoplastic 
epithelial compartment (neoplastic ductal and non-
ductal cells) and in the MMyEC compartment of the 
analyzed PAs. Similarities in immunopositivity to 
MUC-1 antigens in the whole neoplastic epithelial 
cells and MMyECs suggest that a common cell 
gives origin to both sets of neoplastic cells. As it 
was reported in this and in our previous study14, 
positive immunoexpression to MUC-1 protein with 
both HMFG antibodies was found in the cytoplasm 
of the acinar cells of normal labial, submandibular 
and parotid glands. Considering that normal acinar 
salivary gland cells are completely differentiated 
cells, this finding does not support the hypothesis 
that acinar cells may play a role in the histogenesis 
of PAs.
Results from this study show that CMyECs 
surrounding ducts in normal labial salivary glands 
were negative to both HMFG antibodies and that 
in studied PA samples, neoplastic CMyECs were 
negative too. These findings suggest that normal 
CMyECs are not the ancestor cells during PAs 
development and that their role in the ontogenesis 
of these neoplasms needs to be clarified. In 
contrast, we found that all MMyECs in the studied 
PAs (fusiform, hyaline and clear cells and hyaline, 
mucoid, myxoid and chondroid tissue-associated 
cells) stained positively with both tested antibodies. 
The above mentioned findings suggest that MMyECs 
are responsible in part for the wide histologic 
variation of these neoplasms.
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